HuR, also known as ELAVL1, is an RNA‐binding protein, in which lncHCG22 inhibits bladder cancer progression by destabilising HuR proteins to regulate PTBP1 levels. The gene discussed is ELAVL1; the disease is urinary bladder cancer.